Gene, Cell and Tissue

Published by: Kowsar

Can Fusion Proteins Be Considered a New Candidate for Tuberculosis Vaccine?

Sepehr Navid 1 and Masoud Keikha 1 , *
Authors Information
1 Department of Microbiology, School of Medicine, Isfahan Medical University, Isfahan, Iran
Article information
  • Gene, Cell and Tissue: July 2018, 5 (3); e79943
  • Published Online: September 4, 2018
  • Article Type: Letter
  • Received: May 29, 2018
  • Revised: July 2, 2018
  • Accepted: August 30, 2018
  • DOI: 10.5812/gct.79943

To Cite: Navid S, Keikha M. Can Fusion Proteins Be Considered a New Candidate for Tuberculosis Vaccine?, Gene Cell Tissue. 2018 ; 5(3):e79943. doi: 10.5812/gct.79943.

Copyright © 2018, Gene, Cell and Tissue. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
References
  • 1. World Health Organization (WHO). Global tuberculosis report 2015. WHO; 2015.
  • 2. Daniel TM. The history of tuberculosis. Respir Med. 2006;100(11):1862-70. doi: 10.1016/j.rmed.2006.08.006. [PubMed: 16949809].
  • 3. Li W, Deng G, Li M, Zeng J, Zhao L, Liu X, et al. A recombinant adenovirus expressing CFP10, ESAT6, Ag85A and Ag85B of Mycobacterium tuberculosis elicits strong antigen-specific immune responses in mice. Mol Immunol. 2014;62(1):86-95. doi: 10.1016/j.molimm.2014.06.007. [PubMed: 24980867].
  • 4. Soleimanpour S, Farsiani H, Mosavat A, Ghazvini K, Eydgahi MR, Sankian M, et al. APC targeting enhances immunogenicity of a novel multistage Fc-fusion tuberculosis vaccine in mice. Appl Microbiol Biotechnol. 2015;99(24):10467-80. doi: 10.1007/s00253-015-6952-z. [PubMed: 26373723].
  • 5. Pepponi I, Diogo GR, Stylianou E, van Dolleweerd CJ, Drake PM, Paul MJ, et al. Plant-derived recombinant immune complexes as self-adjuvanting TB immunogens for mucosal boosting of BCG. Plant Biotechnol J. 2014;12(7):840-50. doi: 10.1111/pbi.12185. [PubMed: 24629003].
  • 6. Brandt L, Oettinger T, Holm A, Andersen AB, Andersen P. Key epitopes on the ESAT-6 antigen recognized in mice during the recall of protective immunity to Mycobacterium tuberculosis. J Immunol. 1996;157(8):3527-33. [PubMed: 8871652].
  • 7. Liu X, Peng J, Hu L, Luo Y, Niu H, Bai C, et al. A multistage mycobacterium tuberculosis subunit vaccine LT70 including latency antigen Rv2626c induces long-term protection against tuberculosis. Hum Vaccin Immunother. 2016;12(7):1670-7. doi: 10.1080/21645515.2016.1141159. [PubMed: 26901244]. [PubMed Central: PMC4964814].
  • 8. McHeyzer-Williams M, Okitsu S, Wang N, McHeyzer-Williams L. Molecular programming of B cell memory. Nat Rev Immunol. 2011;12(1):24-34. doi: 10.1038/nri3128. [PubMed: 22158414]. [PubMed Central: PMC3947622].
  • 9. Qiao SW, Kobayashi K, Johansen FE, Sollid LM, Andersen JT, Milford E, et al. Dependence of antibody-mediated presentation of antigen on FcRn. Proc Natl Acad Sci U S A. 2008;105(27):9337-42. doi: 10.1073/pnas.0801717105. [PubMed: 18599440]. [PubMed Central: PMC2453734].
  • 10. Levin D, Golding B, Strome SE, Sauna ZE. Fc fusion as a platform technology: potential for modulating immunogenicity. Trends Biotechnol. 2015;33(1):27-34. doi: 10.1016/j.tibtech.2014.11.001. [PubMed: 25488117].
  • 11. Khademi F, Derakhshan M, Yousefi-Avarvand A, Tafaghodi M, Soleimanpour S. Multi-stage subunit vaccines against Mycobacterium tuberculosis: an alternative to the BCG vaccine or a BCG-prime boost? Expert Rev Vaccines. 2018;17(1):31-44. doi: 10.1080/14760584.2018.1406309. [PubMed: 29148853].
  • 12. Mosavat A, Soleimanpour S, Farsiani H, Sadeghian H, Ghazvini K, Sankian M, et al. Fused Mycobacterium tuberculosis multi-stage immunogens with an Fc-delivery system as a promising approach for the development of a tuberculosis vaccine. Infect Genet Evol. 2016;39:163-72. doi: 10.1016/j.meegid.2016.01.027. [PubMed: 26835592].
  • 13. Rowland R, McShane H. Tuberculosis vaccines in clinical trials. Expert Rev Vaccines. 2011;10(5):645-58. doi: 10.1586/erv.11.28. [PubMed: 21604985]. [PubMed Central: PMC3409871].
  • 14. Pitt JM, Blankley S, McShane H, O'Garra A. Vaccination against tuberculosis: how can we better BCG? Microb Pathog. 2013;58:2-16. doi: 10.1016/j.micpath.2012.12.002. [PubMed: 23257069].
  • 15. Langermans JA, Doherty TM, Vervenne RA, van der Laan T, Lyashchenko K, Greenwald R, et al. Protection of macaques against Mycobacterium tuberculosis infection by a subunit vaccine based on a fusion protein of antigen 85B and ESAT-6. Vaccine. 2005;23(21):2740-50. doi: 10.1016/j.vaccine.2004.11.051. [PubMed: 15780721].
  • 16. Doherty TM, Andersen P. Vaccines for tuberculosis: novel concepts and recent progress. Clin Microbiol Rev. 2005;18(4):687-702. doi: 10.1128/CMR.18.4.687-702.2005. [PubMed: 16223953]. [PubMed Central: PMC1265910].
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .
Readers' Comments